PTAB grants IPR win to Celltrion over Biogen

05-10-2018

PTAB grants IPR win to Celltrion over Biogen

tumsasedgars / iStockphoto.com

The Patent Trial and Appeal Board (PTAB) invalidated a patent owned by biotech company Biogen yesterday, handing a victory to South Korea-based Celltrion.


Celltrion, Biogen, PTAB, inter partes review, Patent Trial and Appeal Board, lymphoma, cancer

LSIPR